Regencell Bioscience Holdings Stock Price on April 25, 2023
| RGC Stock | USD 5.21 0.13 2.56% |
If you're considering investing in Regencell Stock, it is important to understand the factors that can impact its price. As of today, the current price of Regencell Bioscience stands at 5.21, as last reported on the 20th of May, with the highest price reaching 5.22 and the lowest price hitting 4.64 during the day. Regencell Bioscience maintains Sharpe Ratio (i.e., Efficiency) of -0.0223, which implies the firm had a -0.0223% return per unit of risk over the last 3 months. Regencell Bioscience exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Regencell Bioscience's Coefficient Of Variation of (6,985), variance of 87.88, and Risk Adjusted Performance of 0.001 to confirm the risk estimate we provide.
The current year's Total Stockholder Equity is expected to grow to about 11.4 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 11.1 M. . At present, Regencell Bioscience's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 10.81, whereas Price To Sales Ratio is forecasted to decline to 0.36. Regencell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Regencell |
Sharpe Ratio = -0.0223
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RGC |
Estimated Market Risk
| 9.55 actual daily | 84 84% of assets are less volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Regencell Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regencell Bioscience by adding Regencell Bioscience to a well-diversified portfolio.
Price Book 4.1212 | Book Value 0.924 | Enterprise Value 56.7 M | Enterprise Value Ebitda (6.99) | Shares Float 1.5 M |
Regencell Bioscience Valuation on April 25, 2023
It is possible to determine the worth of Regencell Bioscience on a given historical date. On April 25, 2023 Regencell was worth 26.8 at the beginning of the trading date compared to the closed value of 26.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Regencell Bioscience stock. Still, in general, we apply an absolute valuation method to find Regencell Bioscience's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regencell Bioscience where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Regencell Bioscience's related companies.
| Open | High | Low | Close | Volume | |
| 26.99 | 26.99 | 26.99 | 26.99 | 61.00 | |
04/25/2023 | 26.80 | 26.80 | 25.90 | 26.80 | 807.00 |
| 26.90 | 26.90 | 26.90 | 26.90 | 867.00 |
| Backtest Regencell Bioscience | | | Regencell Bioscience History | | | Regencell Bioscience Valuation | Previous | Next |
Regencell Bioscience Trading Date Momentum on April 25, 2023
| On April 26 2023 Regencell Bioscience Holdings was traded for 26.90 at the closing time. Highest Regencell Bioscience's price during the trading hours was 26.90 and the lowest price during the day was 26.90 . The net volume was 867. The overall trading history on the 26th of April contributed to the next trading period price growth. The trading delta at closing time to the next next day price was 0.37% . The trading delta at closing time to current price is 3.54% . |
Regencell Bioscience Fundamentals Correlations and Trends
By evaluating Regencell Bioscience's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Regencell Bioscience's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Regencell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Regencell Bioscience Stock history
Regencell Bioscience investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regencell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regencell Bioscience will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regencell Bioscience stock prices may prove useful in developing a viable investing in Regencell Bioscience
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11.7 M | 11.1 M | |
| Net Loss | -6.7 M | -6.4 M |
Regencell Bioscience Stock Technical Analysis
Regencell Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Regencell Bioscience Period Price Range
Low | April 25, 2023
| High |
26.80 | 26.80 |
Regencell Bioscience May 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Regencell Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regencell Bioscience shares will generate the highest return on investment. By undertsting and applying Regencell Bioscience stock market strength indicators, traders can identify Regencell Bioscience Holdings entry and exit signals to maximize returns
Regencell Bioscience Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Regencell Bioscience's price direction in advance. Along with the technical and fundamental analysis of Regencell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regencell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.001 | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (1.58) | |||
| Treynor Ratio | (0.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Regencell Bioscience information on this page should be used as a complementary analysis to other Regencell Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Regencell Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Return On Assets (0.26) | Return On Equity (0.42) |
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.